NHN Investment

NHN Investment Co., Ltd. is a venture capital firm based in Seoul, South Korea, established in 2010 as a subsidiary of NAVER Corporation. The company focuses on providing investments, loans, and management support, along with technological guidance to startups and growing enterprises. NHN Investment primarily targets sectors such as internet, mobile applications, online gaming, e-commerce, information and communication technology, semiconductor industries, advanced genetic engineering, green technology, and medical devices. The firm emphasizes investments in technology-intensive mid-sized ventures and is particularly focused on opportunities within Asia.

Jong-seung Lee

CEO

26 past transactions

IDlayr

Seed Round in 2022
Developer of a mobile authentication technology designed to assist developers in replacing passwords in a secure way. The company's platform confirms ownership of a mobile phone number by verifying the possession of an active SIM card with the same number and provides information on when a SIM card associated with a mobile phone number was last changed, enabling an individual to get a frictionless and secure user authentication technology.

IDlayr

Seed Round in 2021
Developer of a mobile authentication technology designed to assist developers in replacing passwords in a secure way. The company's platform confirms ownership of a mobile phone number by verifying the possession of an active SIM card with the same number and provides information on when a SIM card associated with a mobile phone number was last changed, enabling an individual to get a frictionless and secure user authentication technology.

ImmunoMet

Venture Round in 2021
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, focused on developing and commercializing innovative oncology drugs. Since its incorporation in 2015, the company has concentrated on therapies that enhance the quality of life for cancer patients. Its pipeline includes metabolic regulators that specifically target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors that affect anti-cancer effector T cells. By disrupting cancer metabolism and bolstering anti-cancer immunity, ImmunoMet aims to improve patient survival rates and overall well-being.

Breadfast

Series A in 2020
Breadfast is a Cairo-based company that specializes in producing a variety of bread and bakery products, including white and brown toast, baguettes, multigrain bread, rye, and various types of buns and pastries. Established in 2017, Breadfast operates an online delivery service that ensures customers receive fresh bakery items each morning, eliminating the need for freezing or defrosting. The company's product range also includes different flavors of muffins and croissants, as well as other grocery essentials like milk, eggs, and personal care items. By offering a convenient one-stop platform for daily needs, Breadfast aims to enhance the shopping experience for its customers.

Acquire

Seed Round in 2019
Acquire Inc. is a customer engagement platform that aims to modernize and automate communication for enterprise support and sales teams. Founded in 2014 and headquartered in San Francisco, California, the company provides a comprehensive solution that integrates various communication channels, including live chat, video chat, chatbots, and co-browsing features, all accessible through a unified dashboard. This platform enables businesses to interact with customers and prospects efficiently, reducing response times and enhancing the overall customer experience. Additionally, Acquire's tools facilitate profile management and customer experience automation, contributing to effective sales funnel management and improved client interactions. The company also operates offices in Ahmedabad, India; Boston, Massachusetts; and London, United Kingdom.

LISCure Biosciences

Seed Round in 2019
LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes.

Testim

Series B in 2019
Testim makes it easy for developers and testers to become automation experts, making quality an organization-wide initiative and powering developers to own code quality.

Percepto

Series A in 2019
Percepto is a developer of autonomous drone technology for inspection and surveillance. Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier to making them a must-have platform is the ability of drones to perform tasks autonomously. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

OvationCXM

Series B in 2019
OvationCXM is a technology support company based in Tiburon, California, with an additional office in Scottsdale, Arizona. Founded in 2014, it specializes in providing comprehensive technical support services for businesses across the United States. The company offers 24/7 remote and onsite assistance in various areas, including business technology, network connectivity, and back office support. Its services encompass point-of-sale installations, network configuration, Ethernet cabling, managed routers, software training, and equipment repair. OvationCXM also features a support platform designed to streamline the activation, servicing, and management of technology products, utilizing data and artificial intelligence to predict potential issues and enhance the support experience. This focus on proactive problem-solving and efficient service aims to ensure that businesses receive timely assistance when needed.

BrandTotal

Series A in 2018
BrandTotal Ltd operates a marketing intelligence platform focused on enhancing the effectiveness of marketing campaigns by addressing the challenges of dark marketing. Founded in 2016 and based in Tel Aviv, Israel, the company provides insights into competitive strategies and performances, allowing businesses to measure key performance indicators effectively. By leveraging cyber security, machine learning, and artificial intelligence, BrandTotal's platform enables users to reverse-engineer competitors' marketing strategies, thereby gaining a competitive edge. It collects and consolidates data from various digital channels, offering real-time visibility into brands' marketing activities. This comprehensive approach allows marketing teams to identify threats and opportunities within the digital landscape, enabling them to adjust strategies promptly and make informed decisions.

iMediSync

Series A in 2018
Developer of a medical analysis platform intended to support the diagnosis of dementia by analyzing EEG in a short period. The company's platform allows its users to prevent or slow down dementia by diagnosing the risk of brain diseases in advance, enabling the medical industry to provide integrative mental care through EEG analysis and neuromodulation.

Syte

Series A in 2017
Syte develops a product discovery platform designed to transform the way people search and shop online. It is a provider of visual AI technology that aims to improve retailers’ site navigation, product discovery, and user experience by powering solutions that engage and convert shoppers. The B2B enterprise's solution includes camera search, augmented site search, personalization engines, and smart in-store tools, empower shoppers to discover and purchase products instantly. Their camera solution enables shoppers to take a picture of a product that inspires them and search for visually similar products within a retailer’s site. Up to date, Syte has raised $71 million from investors including Viola Ventures, LG Tech Ventures, NHN Ventures, Kreos Capital, Naver Corporation, Commerce Ventures, Storm Ventures, Axess Ventures, La Maison, MizMaa Ventures, Magma, Naver Corporation, Line Corporation, Reimage Ventures, North Base Media, and KDC Ventures. In 2014, Helge Voss, Idan Pinto, Lihi Pinto Fryman, and Ofer Fryman established Syte in Tel Aviv, Tel Aviv.

Double H, Inc.

Venture Round in 2017
Double H is a start-up venture that provides differentiated wearable health-care devices. It combines light therapy technology with ICT technology. It developed and extended the use of LED technology devices, which previously has been utilized mainly for medical purposes, to personal devices not only with very sophisticated and creative design but also with safety and differentiated functions. It also integrated ICT technology by adding a sensor to the device.

ImmunoMet

Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, focused on developing and commercializing innovative oncology drugs. Since its incorporation in 2015, the company has concentrated on therapies that enhance the quality of life for cancer patients. Its pipeline includes metabolic regulators that specifically target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors that affect anti-cancer effector T cells. By disrupting cancer metabolism and bolstering anti-cancer immunity, ImmunoMet aims to improve patient survival rates and overall well-being.

Celleron Therapeutics

Venture Round in 2017
Celleron Therapeutics Ltd is an oncology company based in Oxford, United Kingdom, that focuses on the clinical development of innovative therapies for cancer treatment. Established in 2004, the company is dedicated to improving patient outcomes by matching treatments to those most likely to respond favorably. Its clinical products include CXD101, an epigenetic immune-regulator designed to enhance the immune system's recognition of tumor cells, and CXD201, derived from the homocamptothecin family, which offers unique chemical properties and improved pharmacological benefits. Celleron's approach incorporates biomarkers developed through epigenetic techniques, aiming to create a new class of mechanism-based cancer drugs that enhance treatment success rates, minimize side effects, and promote cost-effective healthcare solutions.

Sensay

Seed Round in 2016
Sensay, Inc. is a technology company based in Los Angeles, California, that specializes in developing a web-based application designed to facilitate user connections and collaborative assistance. Founded in 2014, Sensay has expanded its offerings to include an AI-powered educational platform aimed at enhancing English language learning. This platform allows English teachers to assign short speaking exercises, with instant feedback provided by voice AI on pronunciation and fluency. Additionally, the company is focused on Web3 technology, developing decentralized applications and blockchain-enabled messaging solutions, including its flagship product, Sense Chat. Through these initiatives, Sensay aims to create innovative solutions that support language learners and foster communication.

Eyefluence

Series B in 2015
Eyefluence, Inc. specializes in developing eye-interaction technology that enables control of augmented reality (AR), virtual reality (VR), and mixed reality (MR) head-mounted displays (HMDs) using eye movements. Founded in 2013 and headquartered in Reno, Nevada, the company combines insights from eye biomechanics and the eye-brain connection to create the fastest interface for HMDs. Eyefluence serves manufacturers in the AR, VR, and MR sectors, focusing on enhancing human communication and interaction within these immersive environments. The company is led by experienced entrepreneurs Jim Marggraff and David Stiehr and boasts a multidisciplinary team of experts in various fields, including optics, engineering, and artificial intelligence. Eyefluence holds a robust intellectual property portfolio with over 30 patents, reflecting its commitment to innovation. The company collaborates with emerging startups and established Fortune 100 firms to promote the adoption of smart glasses for various applications across enterprise, industrial, government, and consumer markets. As of October 2016, Eyefluence operates as a subsidiary of Google Inc.

Avegant

Series B in 2015
Avegant is a technology company developing next-generation display technology to enable previously impossible augmented reality experiences. The company uses its deep scientific understanding of human sight and head-mounted display ergonomics together with its consumer electronics manufacturing experience to develop displays that enable realistic AR experiences for consumers. Avegant was founded in 2012 and headquartered in Belmont, California.

AeroFS

Series B in 2015
AeroFS is an enterprise file sync and share solution. It changes the way creative agencies, consultants, freelancers, and work teams collaborate with their co-workers and clients. The company’s flagship collaboration platform, Amium, makes sharing information and ideas more intuitive and efficient, and dramatically improves and simplifies collaboration with users outside the organization. The service, which stores files in a private cloud-like platform, stores data on the devices designated by the client. AeroFS desktop and server software can run entirely behind a firewall, including authentication. Their vision is to redefine the current view of the ‘cloud’ with better controls, privacy and scalability, whether for administrators, end-users or anyone else.

Avegant

Series A in 2014
Avegant is a technology company developing next-generation display technology to enable previously impossible augmented reality experiences. The company uses its deep scientific understanding of human sight and head-mounted display ergonomics together with its consumer electronics manufacturing experience to develop displays that enable realistic AR experiences for consumers. Avegant was founded in 2012 and headquartered in Belmont, California.

Nexmo

Series C in 2014
Nexmo provides innovative cloud communication APIs that enable applications and enterprises connect to their customers via voice and SMS. Nexmo’s APIs, Direct to Carrier approach and Adaptive Routing technology improves customer experiences by connecting you with your customers reliably no matter where they are in the world. Nexmo connects to over 1,700 carriers and reaches over 235 countries and territories. Nexmo can help any business improve customer communication--some of the world’s top companies like Airbnb, Alibaba, and Snapchat communicate with their global users using Nexmo, across industries ranging from travel, transportation, messaging, e-commerce, finance and payments, and security. Start sending messages and calls in minutes for free at https://www.nexmo.com/

Nexmo

Series B in 2013
Nexmo provides innovative cloud communication APIs that enable applications and enterprises connect to their customers via voice and SMS. Nexmo’s APIs, Direct to Carrier approach and Adaptive Routing technology improves customer experiences by connecting you with your customers reliably no matter where they are in the world. Nexmo connects to over 1,700 carriers and reaches over 235 countries and territories. Nexmo can help any business improve customer communication--some of the world’s top companies like Airbnb, Alibaba, and Snapchat communicate with their global users using Nexmo, across industries ranging from travel, transportation, messaging, e-commerce, finance and payments, and security. Start sending messages and calls in minutes for free at https://www.nexmo.com/

Enders Fund

Seed Round in 2011
Enders Fund is a developer of casual mobile games focused on creating engaging and asynchronous experiences for users. The company specializes in turn-based games that promote social interaction, enabling players to enjoy entertainment on their mobile devices anytime and anywhere. With a small, agile team of developers, Enders Fund maintains a rapid production pace, aiming to release at least 12 new games each year. Their current offerings include various titles such as SpellThis, a social spelling game; TriviaThis, which focuses on pop culture trivia; RepeatThis, a memory game; RankThis, a unique trivia format; and WordThis, a Tetris-style word scrabble game. The company is committed to delivering high-quality and lightweight gaming experiences that resonate with players.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.